(Q33615626)

28 July 2017

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy (English)

1 reference

progressive supranuclear palsy

28 July 2017

multiple system atrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

7

0 references

Bruno Dubois

6

object named as

Bruno Dubois

0 references

Richard G Brown

object named as

Richard G Brown

1

0 references

Albert C. Ludolph

8

object named as

Albert Ludolph

1 reference

28 July 2017

9

Gilbert Bensimon

1 reference

28 July 2017

Lucette Lacomblez

2

1 reference

28 July 2017

Bernard G Landwehrmeyer

3

1 reference

28 July 2017

Thomas Bak

4

1 reference

28 July 2017

Ingo Uttner

5

1 reference

28 July 2017

Christine Payan

10

1 reference

28 July 2017

Nigel P Leigh

11

1 reference

28 July 2017

NNIPPS Study Group

12

1 reference

28 July 2017

language of work or name

English

0 references

publication date

24 June 2010

1 reference

28 July 2017

1 reference

28 July 2017

133

1 reference

28 July 2017

2382-2393

1 reference

28 July 2017

Pt 8

1 reference

Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy

28 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

The Frontal Assessment Battery (FAB): normative values in an Italian population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Visuospatial functions in atypical parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive bedside assessment in atypical parkinsonian syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive function in multiple system atrophy of the cerebellar type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

The European Multiple System Atrophy-Study Group (EMSA-SG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Emotion recognition in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Consensus statement on the diagnosis of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

The North American Multiple System Atrophy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Frontal presentation in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Differentiation of parkinsonian syndromes according to differences in executive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Memory impairment in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Normative data for the Mattis Dementia Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Attentional functions in multiple system atrophy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive performance in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Neuropsychological deficits accompanying striatonigral degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ158

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ158

1 reference

28 July 2017

1 reference